Hofseth Biocare ASA (HBC) — Capital Reinvestment Ratio
Hofseth Biocare ASA (HBC) has a Capital Reinvestment Ratio of 1.43x as of December 2024, meaning it reinvests 1% of its operating cash flow (Nkr851.00K) in capital expenditures (Nkr1.22 Million). See HBC net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hofseth Biocare ASA Capital Reinvestment Ratio (2015–2023)
This chart tracks Hofseth Biocare ASA's Capital Reinvestment Ratio across 2 annual periods. Check cash flow reinvestment rate of Hofseth Biocare ASA to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Hofseth Biocare ASA (2015–2023)
Year-by-year Capital Reinvestment Ratio for Hofseth Biocare ASA from 2015 to 2023. For live market cap and broader valuation context, see Hofseth Biocare ASA market capitalisation.
| Year | Reinvestment Ratio | Operating CF (NOK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 2.97x | Nkr2.76 Million | Nkr8.19 Million | ▲ +99.7% |
| 2015 | 1.49x | Nkr7.97 Million | Nkr11.84 Million | — |